ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,220.27
      -0.05%
      US Tech 100
      17,715.18
      0.19%
      Dow Jones
      39,438.62
      -0.19%
      Brent Oil
      83.225
      1.02%
      Bitcoin
      62,699.49
      2.04%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Palatin Technologies Inc New (PTN)

      7. Palatin Technologies Inc New (PTN) News

      PTN

      Palatin Technologies (PTN)

      Palatin Technologies Inc New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:PTN
      DateTimeSourceHeadlineSymbolCompany
      05/09/20247:30AMPR Newswire (US)Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024AMEX:PTNPalatin Technologies Inc New
      05/02/20247:30AMPR Newswire (US)Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of ObesityAMEX:PTNPalatin Technologies Inc New
      04/30/20247:30AMPR Newswire (US)Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024AMEX:PTNPalatin Technologies Inc New
      04/08/20247:30AMPR Newswire (US)Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024AMEX:PTNPalatin Technologies Inc New
      03/07/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
      03/04/202412:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
      02/28/20247:30AMPR Newswire (US)Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)AMEX:PTNPalatin Technologies Inc New
      02/15/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
      02/15/20247:30AMPR Newswire (US)Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateAMEX:PTNPalatin Technologies Inc New
      02/14/20244:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PTNPalatin Technologies Inc New
      02/14/20242:55PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PTNPalatin Technologies Inc New
      02/09/20247:30AMPR Newswire (US)Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024AMEX:PTNPalatin Technologies Inc New
      02/05/20247:30AMPR Newswire (US)Palatin Announces Database Lock for PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)AMEX:PTNPalatin Technologies Inc New
      02/01/20245:16PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
      02/01/20244:00PMPR Newswire (US)Palatin Announces Closing of $10 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
      02/01/20249:40AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:PTNPalatin Technologies Inc New
      01/30/20248:00AMPR Newswire (US)Palatin Announces $10 Million Registered Direct OfferingAMEX:PTNPalatin Technologies Inc New
      01/08/202410:33AMPR Newswire (US)Palatin Provides Corporate Update and Highlights Strategic Priorities for Calendar Year 2024AMEX:PTNPalatin Technologies Inc New
      01/03/20248:00AMBusiness WireCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide Injection) from Palatin Technologies Inc.AMEX:PTNPalatin Technologies Inc New
      12/20/20239:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
      12/20/20237:30AMPR Newswire (US)Palatin Completes Sale of Vyleesi® to Cosette Pharmaceuticals for up to $171 MillionAMEX:PTNPalatin Technologies Inc New
      12/18/20234:45PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:PTNPalatin Technologies Inc New
      12/18/20234:15PMPR Newswire (US)Palatin Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE AmericanAMEX:PTNPalatin Technologies Inc New
      12/18/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:PTNPalatin Technologies Inc New
      12/15/20234:03PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PTNPalatin Technologies Inc New
      12/08/20235:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
      12/06/20235:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PTNPalatin Technologies Inc New
      12/06/20232:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
      12/04/20235:00PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:PTNPalatin Technologies Inc New
      12/01/20233:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:PTNPalatin Technologies Inc New
       Showing the most relevant articles for your search:AMEX:PTN